Ibex Medical Analytics Receives First FDA 510(k) Clearance
FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer…
Viracta Therapeutics Announces Wind Down of Operations
February 05, 2025 17:00 ET | Source: Viracta Therapeutics, Inc. SAN DIEGO,…
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.
LONDON, MUNICH and NEW DELHI, Feb. 3, 2025 /PRNewswire/ -- Datar Cancer Genetics…
Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
Cayman Islands, January 28, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion”…
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers
January 21, 2025 19:00 ET | Source: ArriVent BioPharma, Inc. Exclusive global…
Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
January 21, 2025 17:00 ET | Source: Adagene Inc. SAN DIEGO and…
ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI
Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review…
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how…
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how…
New NCCN Patient Resource Shares Latest Understanding of Genetic Testing to Guide Patient Decision Making
Free information from the National Comprehensive Cancer Network offers information on how…